Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (101-110 of 230) with videos related to

Pageof 23
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 16, 2013
Cardiac steatosis and left ventricular function in men with metabolic syndromeKristofer Nyman, Marit Granér, Markku O Pentikäinen, et al.
Circulation. Cardiovascular Imaging|January 1, 2015
Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver diseaseMarit Granér, Kristofer Nyman, Reijo Siren, et al.
Diabetes Care|April 29, 2010
Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body compositionMathijs C Bunck, Michaela Diamant, Bjorn Eliasson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemiaMartin Adiels, Jan Borén, Muriel J Caslake, et al.
Journal of Diabetes and Its Complications|February 14, 2013
Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trialsStefano Del Prato, Marja-Riitta Taskinen, David R Owens, et al.
Diabetes Care|August 27, 2011
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetesMathijs C Bunck, Anja Cornér, Bjorn Eliasson, et al.
Journal of Lipid Research|May 1, 2010
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterolLaxman Yetukuri, Sanni Söderlund, Artturi Koivuniemi, et al.
Plos One|September 3, 2011
High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudyLaxman Yetukuri, Ilkka Huopaniemi, Artturi Koivuniemi, et al.
Atherosclerosis|July 18, 2002
A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene clusterHeidi E Lilja, Aino Soro, Kati Ylitalo, et al.
Atherosclerosis|May 30, 2006
The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependentMika Ala-Korpela, Niko Lankinen, Aino Salminen, et al.
Pageof 23

Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 16, 2013
Cardiac steatosis and left ventricular function in men with metabolic syndromeKristofer Nyman, Marit Granér, Markku O Pentikäinen, et al.
Circulation. Cardiovascular Imaging|January 1, 2015
Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver diseaseMarit Granér, Kristofer Nyman, Reijo Siren, et al.
Diabetes Care|April 29, 2010
Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body compositionMathijs C Bunck, Michaela Diamant, Bjorn Eliasson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemiaMartin Adiels, Jan Borén, Muriel J Caslake, et al.
Journal of Diabetes and Its Complications|February 14, 2013
Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trialsStefano Del Prato, Marja-Riitta Taskinen, David R Owens, et al.
Diabetes Care|August 27, 2011
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetesMathijs C Bunck, Anja Cornér, Bjorn Eliasson, et al.
Journal of Lipid Research|May 1, 2010
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterolLaxman Yetukuri, Sanni Söderlund, Artturi Koivuniemi, et al.
Plos One|September 3, 2011
High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudyLaxman Yetukuri, Ilkka Huopaniemi, Artturi Koivuniemi, et al.
Atherosclerosis|July 18, 2002
A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene clusterHeidi E Lilja, Aino Soro, Kati Ylitalo, et al.
Atherosclerosis|May 30, 2006
The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependentMika Ala-Korpela, Niko Lankinen, Aino Salminen, et al.
Pageof 23